Analysis of these TCGA datasets (using PRISURV) [23, 24] revealed longer survival of breast cancer, lung cancer, and cervical cancer patients with high as compared to low NRN1 expression (Supplementary Figure S5A). This evidence concerns the gene NRN1 and lung carcinoma.